OAC
ABOS icon

OMERS Administration Corp’s Acumen Pharmaceuticals ABOS Stock Holding History

OMERS Administration Corp’s Portfolio ABOS Stock Details ABOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$67.5K Buy
28,600
+6,146
+27% +$15.7K ﹤0.01% 1048
2025
Q4 		$47.4K Buy
+22,454
New +$44.5K ﹤0.01% 998
2024
Q2 		– Sell
-23,800
Closed -$96.4K – 1030
2024
Q1 		$96.4K Buy
+23,800
New +$89.7K ﹤0.01% 324

Other funds holding ABOS

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
KIA
Knollwood Investment Advisory Hunt Valley, Maryland $992M AUM 28.95% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

OMERS Administration Corp's ABOS Position: Q1 2026 in Review

OMERS Administration Corp increased its Acumen Pharmaceuticals (ABOS) stake by 27% in Q1 2026, buying an estimated $15.7K and bringing the position to 28,600 shares worth $67.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1048.

OMERS Administration Corp first reported a position in ABOS in Q1 2024 and has held it in 3 quarters since. The position peaked at $96.4K in Q1 2024. 84 funds tracked by Wall St. Rank hold ABOS as of Q1 2026.

  • OMERS Administration Corp held 28,600 shares of Acumen Pharmaceuticals worth $67.5K as of Q1 2026.
  • OMERS Administration Corp bought 6,146 Acumen Pharmaceuticals shares in Q1 2026, an estimated $15.7K.
  • Acumen Pharmaceuticals made up ﹤0.01% of OMERS Administration Corp's portfolio in Q1 2026, its #1048 holding.
  • OMERS Administration Corp first reported a position in Acumen Pharmaceuticals in Q1 2024 and has held it in 3 quarters since.
  • OMERS Administration Corp's Acumen Pharmaceuticals position peaked at $96.4K in Q1 2024.
  • 84 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q1 2026.

Based on OMERS Administration Corp's 13F filing for Q1 2026, filed 15 May 2026.